Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 3.5.2024Bracco Imaging SPA (BRL-5)5726EVueway 0,5 mmol/ml injekčný roztok (sol inj 1x50 ml (liek.inj.skl.))7.6.2024U
 3.5.2024Bracco Imaging SPA (BRL-5)5725EVueway 0,5 mmol/ml injekčný roztok (sol inj 1x30 ml (liek.inj.skl.))3.5.2024U
 3.5.2024Bracco Imaging SPA (BRL-5)5723EVueway 0,5 mmol/ml injekčný roztok (sol inj 1x15 ml (liek.inj.skl.))3.5.2024U
 3.5.2024Bracco Imaging SPA (BRL-5)5721EVueway 0,5 mmol/ml injekčný roztok (sol inj 1x10 ml (liek.inj.skl.))26.4.2024U
 3.5.2024Bracco Imaging SPA (BRL-5)5721EVueway 0,5 mmol/ml injekčný roztok (sol inj 1x10 ml (liek.inj.skl.))26.4.2024U
 3.5.2024Bracco Imaging SPA (BRL-5)5719EVueway 0,5 mmol/ml injekčný roztok (sol inj 1x7,5 ml (liek.inj.skl.))26.4.2024U
 3.5.2024Bracco Imaging SPA (BRL-5)5718EVueway 0,5 mmol/ml injekčný roztok (sol inj 1x3 ml (liek.inj.skl.))26.4.2024U
 3.5.2024Zentiva a.s. (ZNT-SK-2)03417Biston (tbl 50x200 mg (liek.skl.hnedá))6.5.2024O
 3.5.2024Zentiva, k.s. (ZNT-1)01069Fungicidin Léčiva (ung 1x10 g (tuba Al))6.5.2024O
 3.5.2024Zentiva, k.s. (ZNT-1)05476ZODAC (tbl flm 7x10 mg (blis.PVC/PVDC/Al))6.5.2024O
 3.5.2024Zentiva, k.s. (ZNT-1)81835Valzap HCT 160 mg/25 mg (tbl flm 28x160 mg/25 mg (blis.PVC/PE/PVDC/Al))6.5.2024O
 3.5.2024Zentiva, k.s. (ZNT-1)84760Rosucard 20 mg filmom obalené tablety (tbl flm 30x20 mg (blis.OPA/Al/PVC//Al))6.5.2024O
 3.5.2024B.Braun Melsungen AG (BME)13744Braunol (sol der 1x5 l (kanister PE))3.5.2024R
 2.5.2024Upjohn EESV (UPO-NL)62569Norvasc 5 mg tablety (tbl 30x5 mg (blis.PVC/PVDC/Al))6.5.2024R
 2.5.2024Eli Lilly Nederland B.V. (LIL-NL-2)89134Humalog 100 U/ml, injekčný roztok v injekčnej liekovke (sol inj 1x10 ml (liek.inj.skl.))3.5.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)